Ginger in patients with active ulcerative colitis: a study protocol for a randomized controlled trial.

ABSTRACT:

Background

As a lifetime disorder, ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that affects quality of life and also demands long-term interventions. In spite of considerable side effects and sometimes restricted uses, efficient medications are available for UC treatment. Some in vitro and in vivo examinations have correspondingly introduced ginger and its active components with antioxidant, anti-inflammatory, and anti-ulcerative properties. Therefore, this trial aims to evaluate the effect of ginger supplementation on patients with active UC.

Methods

This study will be a 12-week, double-blind, parallel-group, randomized, controlled trial (RCT) in which 44 patients will be allocated to ginger and placebo groups receiving basic routine treatments plus ginge

SUBMITTER: Shayesteh F 

PROVIDER: S-EPMC7079449 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature